Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine

Resilience will manufacture mRNA for Moderna’s COVID-19 Vaccine at its facility in Mississauga, Ontario, Canada.
https://www.businesswire.com/news/home/20210908005443/en/Resilience-to-Manufacture-mRNA-for-Moderna%E2%80%99s-COVID-19-Vaccine

PharmaceuticalInfectious DiseasesBiotechnology